Toggle navigation
Search
Tree View
MeSH on Demand
MeSH 2024
About
Suggestions
Contact Us
avelumab
MeSH Supplementary Concept Data 2025
Details
Concepts
MeSH Supplementary
avelumab
Unique ID
C000609138
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C000609138
Entry Term(s)
MSB-0010682
MSB-0010718C
MSB0010682
MSB0010718C
bavencio
Pharm Action
Antineoplastic Agents, Immunological
Registry Numbers
KXG2PJ551I
Heading Mapped to
*Antibodies, Monoclonal, Humanized
Frequency
334
Note
targets programmed cell death protein-1 ligand; has antineoplastic activity
Source
Cancer Immunol Res. 2015 Oct;3(10):1148-57.
Date of Entry
2016/07/17
Revision Date
2020/07/09
Expand All
Collapse All
avelumab
Preferred
Concept UI
M000619738
Registry Numbers
KXG2PJ551I
Terms
avelumab
Preferred Term
Term UI
T000904221
Date
07/17/2016
LexicalTag
NON
ThesaurusID
MSB0010718C
Narrower
Concept UI
M000619739
Terms
MSB0010718C
Preferred Term
Term UI
T000904220
Date
07/17/2016
LexicalTag
LAB
ThesaurusID
NLM (2016)
MSB-0010718C
Term UI
T000965839
Date
08/20/2019
LexicalTag
LAB
ThesaurusID
NLM (2020)
bavencio
Narrower
Concept UI
M000654339
Terms
bavencio
Preferred Term
Term UI
T000965840
Date
08/20/2019
LexicalTag
NON
ThesaurusID
NLM (2020)
MSB-0010682
Narrower
Concept UI
M000654357
Terms
MSB-0010682
Preferred Term
Term UI
T000965841
Date
08/20/2019
LexicalTag
LAB
ThesaurusID
NLM (2020)
MSB0010682
Term UI
T000965842
Date
08/20/2019
LexicalTag
LAB
ThesaurusID
NLM (2020)
page delivered in 0.004s